23 septiembre 2015
For certain cancer drugs, participants in clinical trials are often not representative of the patients that ultimately take the drugs, raising questions about the direct applicability of trial data, a new article explains.
http://www.sciencedaily.com/releases/2015/09/150923182756.htm
